Healthy Male Clinical Trial
Official title:
A Randomized, Double-blind, Phase I Study Comparing the Pharmacokinetic and Safety of SIBP-04 and Bevacizumab in Healthy Male Subjects
This is a randomised, double-blind, positive drug parallel controlled clinical trial in China. In the trial, it is planned to enroll 88 subjects, randomized to two treatment groups in a ratio of 1:1 to receive the test drug and the positive control.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02395926 -
To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers
|
Phase 1 | |
| Recruiting |
NCT05849311 -
Phase I Trial of Envafolimab for Healthy Male Subjects
|
Phase 1 | |
| Active, not recruiting |
NCT06105255 -
A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
|
Phase 1 | |
| Completed |
NCT01651234 -
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT01359618 -
Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart
|
Phase 1 | |
| Completed |
NCT02395913 -
Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)
|
Phase 1 | |
| Completed |
NCT06194500 -
A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants
|
Phase 1 | |
| Completed |
NCT05202912 -
Food Effect Study of IDX-1197 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04828265 -
Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects
|
Phase 1 |